MehmetAliAgirbasliMD

PubMed

• 2 citations
  Soluble LRP-1 in Parkinson's disease: clues for paradoxical effects.
  Betul Ozdilek, Mehmet Agirbasli
  The International Journal of Neuroscience. 2024-06-01
• Low HDL-C and the Risk of Hospitalisation in Children with COVID-19.
  Nurhan Kasap, Onur Incealtin, Velat Celik, Mehmet Agirbasli
  Journal of the College of Physicians and Surgeons--Pakistan. 2024-04-01
• A randomized double-blind placebo-controlled trial of an inhibitor of plasminogen activator inhibitor-1 (TM5614) in mild to moderate COVID-19.
  Toyohiro Hirai, Koichiro Asano, Isao Ito, Yasunari Miyazaki, Hisatoshi Sugiura
  Scientific Reports. 2024-01-02

Journal Articles

• A randomized double-blind placebo-controlled trial of an inhibitor of plasminogen activator inhibitor-1 (TM5614) in mild to moderate COVID-19.  
  Hirai T, Asano K, Ito I, Miyazaki Y, Sugiura H, Agirbasli M, Kobayashi S, Kobayashi M, Shimada D, Natsume I, Kawasaki T, Ohba T, Tajiri S, Sakamaki F, Mineshita M, Tak..., Scientific Reports, 1/7/2024
• Challenges Before Considering Full-Dose Anticoagulation in Noncritically Ill Patients With COVID-19  
  Agirbasli M, J Am Coll Cardiol, 8/15/2023
• Influence of Diabetes on CABG Patency: Targeting Functional Status After CABG in Patients With DM  
  Agirbasli M, J Am Coll Cardiol, 1/14/2017
• Enhanced mRNA expression of plasminogen activator inhibitor-1 in livedoid vasculopathy lesions  
  Agirbasli M, Goktay F, Peker I, Gunes P, Aker FV, Akkiprik M, Cardiovasc Ther, 1/1/2017
• Free estradiol index levels associated with high sensitivity CRP levels in male children  
  Agirbasli M, Tanrikulu A, Azizy M, Turk J Pediatr, 1/1/2017
• Bone Deformities as a Complication of Giant Thoracic Aortic Aneurysm  
  Aslan A, Kartal Y, Ayaz E, Aslan M, Bulut SSD, Agirbasli MA, Oysu AS, Vasc Endovascular Surg, 1/1/2017
• Potential Causes and Implications of Low Target Therapeutic Ratio in Warfarin-Treated Patients for Thrombosis Prophylaxis  
  Atas H, Sahin AA, Barutcu Atas D, Sunbul M, Kepez A, Agirbasli M, Clin Appl Thromb Hemost, 1/1/2017
• Primordial Prevention of Cardiometabolic Risk in Childhood  
  Tanrikulu MA, Agirbasli M, Berenson G, Adv Exp Med Biol, 1/1/2017
• Treatment with oestrogen-receptor agonists or oxytocin in conjunction with exercise protects against post-menopausal myocardial infarction in rats  
  Bulut EC, Abueid L, Ercan F, Suleymanoglu S, Agirbasli M, Yegen BC, Exp Physiol, 1/9/2016
• Sulfated levan from Halomonas smyrnensis as a bioactive, heparin-mimetic glycan for cardiac tissue engineering applications  
  Erginer M, Akcay A, Coskunkan B, Morova T, Rende D, Bucak S, Baysal N, Ozisik R, Eroglu MS, Agirbasli M, Toksoy Oner E, Carbohydr Polym, 1/1/2016
• Non-alcoholic steatohepatitis score is an independent predictor of right ventricular dysfunction in patients with non-alcoholic fatty liver disease  
  Sunbul M, Kivrak T, Durmus E, Akin H, Aydin Y, Ergelen R, Yilmaz Y, Agirbasli M, Cardiovasc Ther, 1/21/2015
• Heart Failure and Mortality in Patients With Nonvalvular Atrial Fibrillation Started on Novel Oral Anticoagulant Therapy: A Single-Center Experience  
  Sunbul M, Oguz M, Dogan Z, Atas H, Bozbay M, Cincin A, Agirbasli M, Clin Appl Thromb Hemost, 1/12/2015
• A Systems Genetics Approach to Dyslipidemia in Children and Adolescents  
  White MJ, Eren F, Agirbasli D, Chen J, Hu T, Moore JH, Williams SM, Agirbasli M, OMICS, 1/1/2015
• Big data and ethics review for health systems research in LMICs: understanding risk, uncertainty and ignorance and catching the black swans?  
  Dereli T, Coskun Y, Kolker E, Guner O, Agirbasli M, Ozdemir V, Am J Bioeth, 1/1/2014
• Functional stability of plasminogen activator inhibitor-1  
  Yasar Yildiz S, Kuru P, Toksoy Oner E, Agirbasli M, Scientific World Journal, 1/1/2014
• Translating biotechnology to knowledge-based innovation, peace, and development? Deploy a Science Peace Corps-an open letter to world leaders  
  Hekim N, Coskun Y, Sinav A, Abou-Zeid AH, Agirbasli M, Akintola SO, Aynacioglu S, Bayram M, Bragazzi NL, Dandara C, Dereli T, Dove ES, Elbeyli L, Endrenyi L, Erciyas K..., OMICS, 1/1/2014
• Personalized and Participatory Medicine as a Future Tool Combat Cardiovascular Disease in Developing Countries  
  Kuru P, Agirbasli M, Current Pharmacogenomics and Personalized Medicine, 1/1/2014
• Effects of ACE polymorphisms and other risk factors on the severity of coronary artery disease  
  Guney AI, Ergec D, Kirac D, Ozturhan H, Caner M, Koc G, Kaspar C, Ulucan K, Agirbasli M, Genet Mol Res, 1/1/2013
• Tacrolimus Toxicity Reverses the Inhibitory Effects of Renin Angiotensin System Blockade on PAI-1 Expression in Cardiac Tissue  
  Agirbasli M, Bas-Bozkurtlar E, Papilla-Topal N, Deniz H, Ogutmen B, Cakalagaoglu F, Current Enzyme Inhibition, 1/1/2013
• Multi-locus candidate gene analyses of lipid levels in a pediatric Turkish cohort: lessons learned on LPL, CETP, LIPC, ABCA1, and SHBG  
  Agirbasli M, Eren F, Agirbasli D, White MJ, Williams SM, OMICS, 1/1/2013
• Relation between eating habits and a high body mass index among freshman students: a cross-sectional study  
  Gunes FE, Bekiroglu N, Imeryuz N, Agirbasli M, J Am Coll Nutr, 1/1/2012
• Recommendations For Techniques And Components' Selection During Congenital Heart Surgery In Turkey (Derleme)  
  Undar A, Haydin S, Erek E, Yivli P, Odemis E, Agirbasli MA, Alkan-Bozkaya T, Turkoz A, Turkoz R, Sasmazel A, Karaci AR, Cicek AE, Yalcinbas YK, Akcevin A, Tayyar Sario..., Turk Gogus Kalp Damar Cerrahisi Dergisi, 1/1/2012
• Congenital heart surgery in Turkey: Today and Tomorrow (Editorial-Turkish)  
  Undar A, Bakir I, Haydin S, Erek E, Yivli P, Odemis E, Agirbasli MA, Alkan-Bozkaya T, Turkoz A, Turkoz R, Sasmazel A, Karaci AR, Cicek AE, Yalcinbas YK, Akcevin A, Sar..., Turk Gogus Kalp Damar Cerrahisi Dergisi, 1/1/2012
• Enhanced functional stability of plasminogen activator inhibitor-1 in patients with livedoid vasculopathy  
  Agirbasli M, Eren M, Eren F, Murphy SB, Serdar ZA, Seckin D, Zara T, Cem Mat M, Demirkesen C, Vaughan DE, J Thromb Thrombolysis, 1/1/2011
• Congenital heart surgery in Turkey: Today and Tomorrow (Editorial-Turkish)  
  Undar A, Bakir I, Haydin S, Erek E, Yivli P, Odemis E, Agirbasli MA, Alkan-Bozkaya T, Turkoz A, Turkoz R, Sasmazel A, Karaci AR, Cicek AE, Yalcinbas YK, Akcevin A, Sar..., Turkish J Thoracic Cardiovascular Surgery, 1/1/2011
• Join now to see all

Books/Book Chapters

• Biomarkers in Disease: Methods, Discoveries and Applications 
  Chapter: Biomarkers after pediatric heart surgery. 
  Agirbasli M, Zahn D, Undar ASpringer

Abstracts/Posters

• "Sex Hormone Binding Globulin Gene Polymorphisms and Metabolic Syndrome Among Postmenopausal Women"
  Sunbul M, Eren F, Agirbasli M, American Heart Association EPI/NPAM Meeting, 1/1/2011
• Comparison of anthropometric indices in predicting metabolic syndrome components in children.
  Agirbasli M, Agaoglu NB, American College of Cardiology, 1/1/2010
• Enhanced stability of plasminogen activator inhibitor-1 in patients with livedoid vasculopathy.
  Agirbasli M, Eren M, Vaughan DE, American Heart Association, 1/1/2009
• The Effects of Sex Hormones on Lipid Levels in Children and Adolescents.
  Agirbasli M, Agaoglu NB, Orak N, Caglioz H, Ocek T, Baykan O, American College of Cardiology, 1/1/2009
• Interaction among MTHFR, PAI-1, ACE, PON AND ECNOS Gene Polymorphisms can predict the presence and severity of early onset coronary artery disease.
  Agirbasli M, Ozturhan HS, Ulucan K, Agirbasli D, Sevinc D, Ryckman K, Williams SM, Guney AI, American College of Cardiology, 1/1/2009
• Resolution of ECG and Echocardiographic Changes in Young Patients after ST Elevation Myocardial Infarction.
  Tanrikulu A., Agirbasli M, European Atherosclerosis Society Meeting, 1/1/2008
• Effects of LCAT Polymorphisms on HDL-C Levels in Turkish Population.
  Agirbasli D, Agirbasli M., Sumerkan M, Aral C, Aksoy S, Karabulut S, Cirakoglu B, European Human Genetic Conference, 1/1/2008
• Combined Effects of ACEIs AND ARBs Onplasma Inflammatory and Fibrinolytic Markers.
  Cincin A, Baykan O, Agirbasli M, European Atherosclerosis Society Meeting, 1/1/2008
• Dietary, Physical Activity and Anthropometric Measurements in Low to Middle Socioeconomical Status Turkish Children.
  Agaoglu NB, Baykan O, Orak N, Arikan S, Aksoy C, Agirbasli M, European Atherosclerosis Society Meeting, 1/1/2008
• Comparison of Anthropometric Measurements in Turkish versus German Children.
  Schwandt P., Haas G.M., Baykan A.O., Agaoglu N.B., Liepold E., Agirbasli M, European Atherosclerosis Society Meeting, 1/1/2008
• Short term effects of GNHR agonists on plasma fibrinolytic system in metastatic prostate cancer.
  Baykan O., Cincin A., Tekin A., Sengor F. Demir M., Agirbasli M, European Atherosclerosis Society Meeting, 1/1/2008
• Frequency, Significance and Association of Ace and MTHFR Gene Polymorphisms in Turkish Patients with Early Onset Coronary Artery Disease.
  Ozturhan HS, Guney I, Sevinc D, Agirbasli D, Baykan O, Agirbasli M, European Atherosclerosis Society Meeting, 1/1/2008
• Comparison of lipoprotein levels in Turkish versus German children.
  Agirbasli M., Haas G.M., Baykan A.O., Agaoglu N.B., Liepold E., Schwandt P, European Atherosclerosis Society Meeting, 1/1/2008
• Preheparin serum lipoprotein lipase mass in metabolic syndrome and coronary heart disease: interaction with gender, gene polymorphism and smoking.
  Hergenc G, Onat A., Agirbasli M., Kaya Z., Can. G., Eginel Unaltuna N, European Atherosclerosis Society Meeting, 1/1/2008
• Association of Fibrinolytic Parameters with SLE.
  Bicakcigil M, Tasan D, Akpinar I, Agirbasli M, Yavuz S, Annals of the Rheumatic Diseases, 1/1/2007
• Interaction among 5, 10 methylenetetrahydrofolate reductase, plasminogen activator inhibitor and endothelial nitric oxide synthase gene polymorphisms predicts the seve...
  Agirbasli D, Agirbasli M, Williams SM, Phillips JA, European Human Genetic Conference, 1/1/2006
• PAI-1 Hind III Restriction Fragment Length Polymorphism as a Risk for Early Onset Coronary Artery Disease.
  Agirbasli D, Agirbasli M, Erarslan S, Alkan T, Kirdar B, Byrne DW, Phillips JA, Thrombosis, Hemostasis and Angiology Congress, 1/1/2003
• PAI-1 Turk populasyonunda koroner arter hastaliginin PAI-1 ve MTHFR polimorfizmleriyle iliskisi.
  Agirbasli D, Agirbasli M, Erarslan S, Kirdar B, Byrne DW, Williams SM, Phillips JA, Thrombosis, Hemostasis and Angiology Congress, 1/1/2003
• Agonist induklu trombosit agregasyonuna taksolun etkisi.
  Kanmaz-Demircioglu AS, Ozsavci D, Tetik S, Oba R, Agirbasli M, Yardimci T, Thrombosis, Hemostasis and Angiology Congress, 1/1/2003
• Comparison of ACEI and ARB on their Effects on Fibrinolytic Balance from a Biological Stand Point.
  Agirbasli M, Turkish Cardiology Society Meeting, 1/1/1999
• "Apolipoprotein E Levels in Pediatric Heart Surgery"
  Agirbasli M, Undar A, 10th International Conference on Pediatrc Mechanical Circulatory Support Systems & Pediatric Cardiopulmonary Perfusion, University of Pennsylvania, Hall of Flags, Philadelphia, PA
• Join now to see all

Lectures

• "Results of SAVE study" 
  Antalya, Turkey - 1/1/2018
• "Hs-CTn in MI" 
  Antalya, Turkey - 1/1/2018
• "NOAC use in cardiology." 
  Istanbul, Turkey - 1/1/2015
• "Apolipoprotein E levels after pediatric heart surgery." 
  University of Pennsylvania, Hall of Flags, Philadelphia, PA - 1/1/2014
• "Reperfusion after myocardial infarction in Istanbul." 
  1/1/2013
• "Biomarkers of neurological injury after pediatric cardiac surgery." 
  Hershey, MA - 1/1/2013
• "International coolaboration in the era of high throughput Technologies" 
  Hershey, MA - 1/1/2013
• "Triple therapy after PCI." 
  Antalya, Turkey - 1/1/2012
• Primary percutaneous intervention versus thrombolysis in acute myocardial infarction. 
  Istanbul, Turkey - 1/1/2011
• Catheterization after bypass surgery. 
  1/1/2011
• Assessment of multiple biomarkers after pediatric congenital heart surgery. 
  Istanbul, Turkey - 1/1/2011
• Novel developments in personalized medicine. 
  Bodrum, Turkey - 1/1/2011
• "Hipertrigliseridemi nasil tedavi edilir." 
  Istanbul, Turkey - 1/1/2011
• Feability of multiple biomarker assessment after pediatric cardiac surgery. 
  Boston, MA - 1/1/2010
• ApoCIII as a cardivascular risk Indicator. 
  1/1/2010
• "Novel anticoagulant agents." 
  1/1/2010
• Interventional Cardiology 
  1/1/2009
• "Novel cardiovascular risk factors and obesity." 
  1/1/2008
• "Difficult Interventional Cardiology cases panel discussion." 
  1/1/2008
• "Drug eluting stents." 
  1/1/2008
• "PCI versus surgery for multivessel coronary artery disease." 
  1/1/2007
• "Hybrid Coronary Revascularization" 
  1/1/2007
• "PCI after 12 hours in ST elevation myocardial infarction." 
  Antalya, Turkey - 1/1/2006
• "Cardiac complications after cardiothoracic surgery: cardiologist's view." 
  Antalya, Turkey - 1/1/2004
• "Post-operative cardiac complications." 
  1/1/2004
• Join now to see all